| __timestamp | BioMarin Pharmaceutical Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 15411924 |
| Thursday, January 1, 2015 | 634806000 | 22593274 |
| Friday, January 1, 2016 | 661905000 | 33173050 |
| Sunday, January 1, 2017 | 610753000 | 62224159 |
| Monday, January 1, 2018 | 696328000 | 95607434 |
| Tuesday, January 1, 2019 | 715007000 | 221269028 |
| Wednesday, January 1, 2020 | 628116000 | 400745069 |
| Friday, January 1, 2021 | 628793000 | 580520000 |
| Saturday, January 1, 2022 | 649606000 | 663366000 |
| Sunday, January 1, 2023 | 746773000 | 755113687 |
| Monday, January 1, 2024 | 747184000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) investments are crucial for driving innovation and maintaining a competitive edge. Over the past decade, argenx SE and BioMarin Pharmaceutical Inc. have demonstrated significant commitment to R&D, with both companies showing remarkable growth in their investments.
From 2014 to 2023, BioMarin's R&D expenses grew by approximately 62%, reflecting their dedication to advancing therapeutic solutions. Meanwhile, argenx SE, a rising star in the biotech industry, increased its R&D spending by an astounding 4,800%, showcasing its aggressive pursuit of groundbreaking treatments. By 2023, argenx SE's R&D expenses slightly surpassed those of BioMarin, highlighting its rapid ascent in the industry.
As these companies continue to invest heavily in R&D, the biotech sector can anticipate a wave of innovative therapies that promise to transform patient care globally.
Regeneron Pharmaceuticals, Inc. or argenx SE: Who Invests More in Innovation?
argenx SE or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
argenx SE vs Halozyme Therapeutics, Inc.: Strategic Focus on R&D Spending
argenx SE or Ascendis Pharma A/S: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for argenx SE and Ultragenyx Pharmaceutical Inc.
Research and Development Expenses Breakdown: argenx SE vs Xenon Pharmaceuticals Inc.
Research and Development Investment: argenx SE vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs BioMarin Pharmaceutical Inc.
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for BioMarin Pharmaceutical Inc. and Viking Therapeutics, Inc.
R&D Spending Showdown: BioMarin Pharmaceutical Inc. vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Celldex Therapeutics, Inc.